Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases?

Nicola Scichilone, Alida Benfante, Pierluigi Paggiaro, Marialuisa Bocchino, Alessandro Sanduzzi, Alberto Papi, Fulvio Braido, Pierachille Santus

Risultato della ricerca: Article

28 Citazioni (Scopus)

Abstract

Inhalation is the preferred route of drug administration in chronic respiratory diseases because it optimises delivery of the active compounds to the targeted site and minimises side effects from systemic distribution. The choice of a device should be made after careful evaluation of the patient's clinical condition (degree of airway obstruction, comorbidities), as well as their ability to coordinate the inhalation manoeuvre and to generate sufficient inspiratory flow. These patient factors must be aligned with the specific advantages and limitations of each inhaler when making this important choice. Finally, adherence to treatment is not the responsibility of the patient alone, but should be shared also by clinicians. Clinicians have access to a wide selection of pressurised metered dose inhalers (pMDIs) and dry powder inhalers (DPIs) that can be used effectively when matched to the needs of individual patients; this should be perceived as an opportunity rather than a limitation.
Lingua originaleEnglish
pagine (da-a)63-67-67
Numero di pagine5
RivistaPULMONARY PHARMACOLOGY & THERAPEUTICS
Volume31
Stato di pubblicazionePublished - 2015

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine
  • Biochemistry, medical
  • Pharmacology (medical)

Fingerprint Entra nei temi di ricerca di 'Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases?'. Insieme formano una fingerprint unica.

  • Cita questo